Precision BioSciences, Inc.

Informe acción NasdaqCM:DTIL

Capitalización de mercado: US$72.8m

Salud financiera de hoja de balance de Precision BioSciences

Salud financiera controles de criterios 5/6

Precision BioSciences tiene un patrimonio de los accionistas total de $18.9M y una deuda total de $22.4M, lo que sitúa su ratio deuda-patrimonio en 118.8%. Sus activos y pasivos totales son $159.8M y $140.9M respectivamente.

Información clave

118.8%

Ratio deuda-patrimonio

US$22.41m

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$116.68m
PatrimonioUS$18.86m
Total pasivoUS$140.92m
Activos totalesUS$159.78m

Actualizaciones recientes sobre salud financiera

Is Precision BioSciences (NASDAQ:DTIL) Using Debt In A Risky Way?

Mar 14
Is Precision BioSciences (NASDAQ:DTIL) Using Debt In A Risky Way?

Is Precision BioSciences (NASDAQ:DTIL) Weighed On By Its Debt Load?

Dec 08
Is Precision BioSciences (NASDAQ:DTIL) Weighed On By Its Debt Load?

Despite Lacking Profits Precision BioSciences (NASDAQ:DTIL) Seems To Be On Top Of Its Debt

Apr 19
Despite Lacking Profits Precision BioSciences (NASDAQ:DTIL) Seems To Be On Top Of Its Debt

Precision BioSciences (NASDAQ:DTIL) Is Using Debt Safely

Dec 31
Precision BioSciences (NASDAQ:DTIL) Is Using Debt Safely

Recent updates

Analysts Just Made A Meaningful Upgrade To Their Precision BioSciences, Inc. (NASDAQ:DTIL) Forecasts

Aug 06
Analysts Just Made A Meaningful Upgrade To Their Precision BioSciences, Inc. (NASDAQ:DTIL) Forecasts

It's Down 29% But Precision BioSciences, Inc. (NASDAQ:DTIL) Could Be Riskier Than It Looks

Jun 23
It's Down 29% But Precision BioSciences, Inc. (NASDAQ:DTIL) Could Be Riskier Than It Looks

Is Precision BioSciences (NASDAQ:DTIL) Using Debt In A Risky Way?

Mar 14
Is Precision BioSciences (NASDAQ:DTIL) Using Debt In A Risky Way?

Is Precision BioSciences (NASDAQ:DTIL) Weighed On By Its Debt Load?

Dec 08
Is Precision BioSciences (NASDAQ:DTIL) Weighed On By Its Debt Load?

Precision BioSciences appoints chief business officer from within ranks, rejigs co-founders' roles

Sep 02

Precision BioSciences: CAR T Data Updates End Of 2022 And Plenty Of Cash

Aug 16

Precision BioSciences Q2 2022 Earnings Preview

Aug 05

Precision Bio: Another CAR-T Laggard With No Solid Prospects

May 09

Despite Lacking Profits Precision BioSciences (NASDAQ:DTIL) Seems To Be On Top Of Its Debt

Apr 19
Despite Lacking Profits Precision BioSciences (NASDAQ:DTIL) Seems To Be On Top Of Its Debt

Analyst Forecasts Just Became More Bearish On Precision BioSciences, Inc. (NASDAQ:DTIL)

Mar 21
Analyst Forecasts Just Became More Bearish On Precision BioSciences, Inc. (NASDAQ:DTIL)

Precision BioSciences (NASDAQ:DTIL) Is Using Debt Safely

Dec 31
Precision BioSciences (NASDAQ:DTIL) Is Using Debt Safely

Precision BioSciences: Uniquely Positioned

Oct 07

Is Precision BioSciences (NASDAQ:DTIL) A Risky Investment?

Sep 24
Is Precision BioSciences (NASDAQ:DTIL) A Risky Investment?

Precision BioSciences: The Right Profile To Progress

Aug 27

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($136.4M) de DTIL superan a sus pasivos a corto plazo ($50.0M).

Pasivo a largo plazo: Los activos a corto plazo de DTIL ($136.4M) superan a sus pasivos a largo plazo ($90.9M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: DTIL tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de DTIL ha crecido de 0% a 118.8% en los últimos 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: DTIL tiene suficiente cash runway para más de un año basándose en su flujo de caja libre actual.

Pronóstico de cash runway: DTIL dispone de suficiente cash runway para 1.5 años si el flujo de caja libre sigue creciendo a tasas históricas de 0.9% cada año.


Descubre empresas con salud financiera